Jeffrey Vacirca

Jeffrey L.
Vacirca is the founder of National Translational Research Group, Inc. (founded in 2011) and holds the title of President.
He is also the founder of New York Cancer Foundation.
Dr. Vacirca's current job(s) include Chairman, CEO & Director-Clinical Research at New York Cancer Specialists (since 2008), Medical Director at The Mount Sinai Hospital (since 2018), Medical Director at AmerisourceBergen Specialty Group LLC (since 2012), Director at American Red Cross in Greater New York, Director at OneOncology LLC (since 2018), Medical Director at International Oncology Network LLC, Director at Community Oncology Alliance, Inc. (starting in 2023), Independent Director at Assertio Holdings, Inc. (starting in 2023), Director at Annexus Health LLC (since 2021), and Associate Clinical Professor at Icahn School of Medicine at Mount Sinai (since 2018).
Dr. Vacirca's former job(s) include Vice Chairman at Odonate, Inc. (2016-2019), Independent Director at Spectrum Pharmaceuticals, Inc. (2018-2023), Independent Director at BeyondSpring, Inc. (2020-2022), and President at Community Oncology Alliance, Inc. (2017-2019).
Dr. Vacirca's education history includes an undergraduate degree from State University of New York at Albany and a doctorate degree from St. Georges University School of Medicine.
Dr. Vacirca is also the founder of New York Cancer Foundation.